Real-world Study of UTD1 in Chinese Advanced Breast Cancer

Fudan University

Status: Completed

Conditions: Breast Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT05386511

YOUNGBC-17

Details and patient eligibility

About

To evaluate the efficacy and safety of UTD1 in patients with advanced breast cancer.

Enrollment: 150 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients aged over 18 years old.
2. Metastatic breast cancer included unresectable locally advanced breast cancer, de novo stage IV breast cancer, and recurrent metastatic breast cancer.
3. Plan to receive or has received UTD1 monotherapy or UTD1 based therapy
4. Available medical history.

Exclusion criteria

1.Incomplete medical history.

Trial design

150 participants in 1 patient group

UTD1

Description:

UTD1 monotherapy or UTD1 based therapy